Pugin 1991 clinical pulmonary infection score (CPIS, max 12) from temperature, leukocytes and band forms, tracheal secretions, PaO2/FiO2 with ARDS, chest radiograph, and tracheal-aspirate culture. Band CPIS>6 follows the 1991 derivation correlation. Not a VAP diagnosis or Singh modified CPIS.

Schaper 2004 IWGDF PEDIS: five independent grades, not a summed total. Perfusion 1-3 (no PAD; PAD without CLI; CLI). Extent 1-3 (<1; 1-3; >3 cm2). Depth 1-3 (superficial; fascia/muscle/tendon; bone/joint). Infection 1-4 (none; skin; deeper without SIRS; with SIRS). Sensation 1-2 (protective sensation present or lost). Label like 1-1-1-1-1. Caller assigns grades. Not a medical device or IWGDF treatment; magent does not measure the ulcer, diagnose PAD, or probe bone.

Chopard 2006 Geneva score for VTE prophylaxis in acutely ill medical inpatients. Eleven 2-point factors plus eight 1-point factors including age >60. Max 30. Score <3 low; >=3 high (prophylaxis indicated). Not a diagnosis or order. Not Revised Geneva PE. Not Padua.

Carmona-Bayonas 2015 CISNE: ECOG ≥2 (2), stress hyperglycemia (2), COPD (1), chronic cardiovascular disease (1), NCI CTC mucositis ≥2 (1), monocytes <200/µL (1). Max 8. Low 0, intermediate 1–2, high ≥3. Seemingly stable adult solid-tumor febrile neutropenia only. Deterministic published score with citation; not MASCC; not an outpatient-chemotherapy or discharge order. magent does not assign ECOG, assay glucose, diagnose COPD, read an echocardiogram, grade mucositis, or count monocytes.

MASCC risk index from Klastersky 2000: one burden-of-illness value (none_or_mild 5, moderate 3, severe 0) plus no hypotension (5), no COPD (4), solid tumor or hematologic malignancy without previous fungal infection (4), outpatient (3), no dehydration (3), and age <60 (2). Max 26; low-risk ≥21. Deterministic published arithmetic with citation; not an outpatient-chemotherapy order; magent does not read a blood pressure.

Raff 2017 ALT-70 for lower-extremity cellulitis vs pseudocellulitis. Caller-assigned unilateral involvement (3), WBC ≥10,000/µL (1), heart rate ≥90 (1), age ≥70 (2); max 7. Bands 0-2 (pseudocellulitis-leaning), 3-4 (indeterminate), and ≥5 (cellulitis-leaning). Deterministic published score with citation; not a medical device, not a cellulitis diagnosis, and not an antibiotic order. magent does not examine the limb.

Khan 2024 AHA PREVENT base 10-year total CVD percent (ASCVD plus heart failure) for age 30-79 from sex, lipids, treated systolic BP, diabetes, smoking, eGFR, BMI, antihypertensive, and statin. Sex-specific, race-free Table S12 coefficients. Not 30-year, not ASCVD-only, not HF-only, not 2013 PCE, not SCORE2, not a diagnosis or statin order. magent does not assay lipids.

Lipsett 2022 Pneumonia Risk Score for children 3 months to 18 years: logistic probability of radiographic pneumonia from age, triage oxygen saturation, fever, rales, and wheeze, plus the published supplement integer score 1–6. Caller-assigned findings. Not a diagnosis, not a CXR order, and not adult CURB-65.

Sanfilippo 2019 IMPEDE VTE for multiple myeloma: IMiD 4, BMI>=25 1, pelvic/hip/femur fracture 4, ESA 1, doxorubicin 3, dexamethasone none/low/high 0/2/4 (high if monthly >160 mg), Asian/Pacific Islander -3 (caller-assigned), VTE history 5, tunneled line 2, thromboprophylaxis none/prophylactic/therapeutic 0/-3/-4. Unclamped. <=3 low 3.3%, 4-7 intermediate 8.3%, >=8 high 15.2%. Not a prophylaxis order. Not SAVED or Khorana.

ASAS 2009 axial SpA classification (Rudwaleit set 3a / fig 2). Required: chronic back pain ≥3 months and age at onset <45. Imaging arm: MRI or modified New York sacroiliitis plus ≥1 of 11 SpA features. Clinical arm: HLA-B27 plus ≥2 other features (HLA-B27 does not count toward those two). Not a diagnosis. Not peripheral ASAS 2011. Not modified New York AS-only. magent does not read films or assay HLA-B27.

ASAS 2011 peripheral SpA classification (Rudwaleit set 2D / fig 1 + table 5). Required: current arthritis, enthesitis, or dactylitis. Arm A: ≥1 of psoriasis, IBD, preceding infection, HLA-B27, uveitis, sacroiliitis on imaging. Arm B: ≥2 of arthritis, enthesitis, dactylitis, IBP in the past, family history of SpA. Not a diagnosis. Not ASAS 2009 axial. Not ESSG/Amor. magent does not examine joints or assay HLA-B27.

Lukas 2009 ASDAS-ESR: 0.08*back pain + 0.07*morning stiffness duration + 0.11*patient global + 0.09*peripheral pain/swelling + 0.29*sqrt(ESR). BASDAI 0-10 items and ESR in mm/h. magent does not examine the patient or assay ESR. Not ASDAS-CRP. Not BASDAI total. Does not apply Machado 2011 1.3/2.1/3.5 activity cuts. Not a diagnosis or biologic order.

Aletaha 2005 Clinical Disease Activity Index (CDAI) for rheumatoid arthritis: SJC28 + TJC28 + patient global (0–10 cm) + evaluator global (0–10 cm). No CRP. Half points allowed; the sum is not integer-rounded. magent does not count joints. Arthritis Res Ther 2005 (ar1740) validates the sum and does not publish activity-state cutoffs. Not SDAI. Not Crohn's CDAI. Not a rheumatoid arthritis diagnosis.

van der Heijde 2009 ASDAS-CRP: 0.12*back pain + 0.06*morning stiffness duration + 0.11*patient global + 0.07*peripheral pain/swelling + 0.58*ln(CRP+1). BASDAI 0-10 items and CRP in mg/L. ASAS selected the CRP version as preferred. magent does not examine the patient or assay CRP. Not ASDAS-ESR. Not BASDAI total. Does not apply Machado 2011 1.3/2.1/3.5 activity cuts. Not a diagnosis or biologic order.

AHA 2017 classic/complete Kawasaki disease (McCrindle). Complete when fever_days >= 4 and at least 4 of 5 principal features are true (oral mucosal changes, bilateral conjunctival injection, rash, extremity changes, cervical lymphadenopathy). Does not implement the incomplete-KD lab/echo algorithm or the 3-day clinician exception. magent does not examine the patient or read an echocardiogram. Not a medical device and not a diagnosis.

ACR/EULAR 2012 PMR classification (Dasgupta Table 4). Required: age 50–120, bilateral shoulder aching, abnormal CRP or ESR. Score morning stiffness >45 min 2, hip pain or limited ROM 1, RF or ACPA absent 2, other joint pain absent 1. Without ultrasound: max 6, classified iff ≥4. With ultrasound: add shoulder-and-hip 1 and both shoulders 1; max 8, classified iff ≥5. Not a diagnosis (not meant for diagnostic purposes). magent does not assay CRP/ESR/RF/ACPA or perform ultrasound.

ACR/EULAR 2016 primary Sjögren classification (Shiboski Table 3). Required: inclusion_met true (AECG dryness or ESSDAI domain) and exclusion_present false (no radiation, HCV, AIDS, sarcoid, amyloid, GVHD, IgG4-RD). Score: labial biopsy FS ≥1 3, anti-SSA/Ro 3, ocular staining 1, Schirmer 1, UWS 1; max 9; classified iff ≥4. Not a diagnosis. Not AECG 2002. Not 2012 ACR-only. magent does not stain eyes, measure saliva, or read biopsies.

Prevoo 1995 DAS28-ESR: 0.56*sqrt(tjc28) + 0.28*sqrt(sjc28) + 0.70*ln(esr_mm_h) + 0.014*gh (0-100 mm VAS, not 0-10 CDAI/SDAI). Caller-assigned 28-joint counts 0-28; ESR strictly >0 (typical 1-150). magent does not count joints or assay ESR. Score only; Prevoo 1995 does not publish later EULAR 2.6/3.2/5.1 cutoffs. Not SDAI, not CDAI, not DAS28-CRP. Not a rheumatoid arthritis diagnosis.

Wells 2009 DAS28(CRP): 0.56*sqrt(TJC28)+0.28*sqrt(SJC28)+0.014*GH+0.36*ln(CRP+1)+0.96. CRP is mg/L, not SDAI mg/dL. GH is 0-100 mm VAS, not 0-10. The +0.96 constant is required. Remission is DAS28<2.6 as stated in that paper. magent does not count joints or assay CRP. Not DAS28-ESR, SDAI, or CDAI. Not a rheumatoid arthritis diagnosis.

Samuel 2002 pediatric appendicitis score from eight caller-assigned findings, ages 4-15, max 10. Cough/percussion/hopping RLQ and RIF tenderness score 2; anorexia, pyrexia, nausea/emesis, leukocytosis, neutrophilia, and migration score 1. Fever and labs are flags, not unpublished cutoffs. Not Alvarado (MANTRELS). Not a diagnosis or operating-room protocol. magent does not examine the abdomen.